Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 16.707\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CC(C)C(NC(=O)C1CCCCC1)C(=O)Nc1ccccn1
b. NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O
c. CC(Sc1nncn1C)C(=O)Nc1ccccc1-c1ccccc1
Answer: c. CC(Sc1nncn1C)C(=O)Nc1ccccc1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Sc1nncn1C)C(=O)Nc1ccccc1-c1ccccc1
CC(Sc1nncn1C)C(=O)Nc1ccccc1-c1ccccc1
[C][C][Branch1][#Branch2][S][C][=N][N][=C][N][Ring1][Branch1][C][C][=Branch1][C][=O][N][C][=C][C][=C][C][=C][Ring1][=Branch1][C][=C][C][=C][C][=C][Ring1][=Branch1]
2-[(4-methyl-1,2,4-triazol-3-yl)-sulfanyl]-N-(2-phenylphenyl)propanamide